Replication of poliovirus in human mononuclear phagocyte cell lines is dependent on the stage of cell differentiation

M Roivainen1, T Hovi

  • 1Department of Virology, National Public Health Institute, Helsinki, Finland.

Insights

Poliovirus type 3 replicates in U-937 cells. However, phorbol ester treatment renders these cells nonpermissive for poliovirus, suggesting a model for studying virus-leukocyte interactions.

Area of Science:

  • Virology
  • Cell Biology
  • Immunology

Background:

  • Poliovirus infects various cell types.
  • U-937 cells are derived from human histiocytic lymphoma.
  • Understanding virus-host interactions is crucial.

Purpose of the Study:

  • To investigate poliovirus type 3 replication in U-937 cells.
  • To determine the effect of phorbol ester (PMA) on poliovirus replication.
  • To explore U-937 cells as a model for poliovirus-leukocyte interactions.

Main Methods:

  • Culturing U-937 and RC2A cell lines.
  • Infecting cells with wild-type and attenuated poliovirus type 3.
  • Treating U-937 cells with phorbol ester (PMA).
  • Assessing viral replication via progeny virus production.
  • Testing vesicular stomatitis virus replication.

Main Results:

  • Both wild-type and attenuated poliovirus type 3 replicated in untreated U-937 cells.
  • PMA treatment rendered U-937 cells nonpermissive for poliovirus replication.
  • PMA treatment did not affect vesicular stomatitis virus replication in U-937 cells.
  • RC2A cells showed no detectable poliovirus progeny production.

Conclusions:

  • U-937 cells support poliovirus type 3 replication.
  • PMA-induced differentiation of U-937 cells inhibits poliovirus replication.
  • U-937 cells, particularly after PMA treatment, may serve as a valuable model for poliovirus-leukocyte interactions.